Immunohematology Market Analysis by Product (Immunohematology Analyzer, Immunohematology Reagent), By End Use (Hospitals, Blood banks, Diagnostic Laboratories), By Region (North America, Europe, APAC, LATAM & MEA) And Segment Forecasts, 2013 - 2024

Published: Dec, 2016 | Pages: 120 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global immunohematology market is expected to reach a value of USD 2.3 billion by 2024, according to a new report by Grand View Research, Inc. This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.Involvement of government organizations and NGOs is vast in this field.

Use of technology is contributing to the growth in the market. Use of mobile applications helps in tracking the blood donation activity of volunteer donors and also reminds them to donate regularly. In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.

Further Key Findings from the Study Suggest:

Immunohematology reagents dominated the product segment in 2015 due to huge product variety and an increasing number of blood banks procuring these reagents. The innovations in the field are resulting in new product launches and also the efforts are acknowledged at a global level.

In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.

Hospitals dominated the end-use segment in 2015 due to increasing number of emergency cases because of road accidents and other types of trauma. Governments and investors are increasingly investing in expanding and upgrading emergency departments in hospitals to cater to the growing demand and increase the chances of survival of trauma patients.

In 2015, North America dominated the market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.

Some of the key industry players are Hologic, Inc., Bio-Rad Laboratories, Inc.; Grifols, ThermoFisher, Immucor; Ortho Clinical Diagnostics; BD (Becton Dickinson); Siemens Healthcare GmbH; Abbott; and Beckman Coulter, Inc.

 Table of Content


Chapter 1 Research Methodology
                    1.1 Information Procurement
                    1.2 Data Analysis
Chapter 2 Executive Summary
                    2.1 Market Snapshot
Chapter 3 Market Variables, Trends& Scope
                    3.1 Market Segmentation and Scope
                         3.1.1 Market driver analysis
                              3.1.1.1 Increasing rate of trauma injuries
                              3.1.1.2 Industry players introducing new products
                              3.1.1.3 Rising prevalence of target diseases
                         3.1.2 Market restraint analysis
                              3.1.2.1 High cost of products 
                    3.2 Penetration & Growth Prospects Mapping
                    3.3 Immunohematology Market - PESTLE Analysis
                    3.4 Industry Analysis - Porter's
                    3.5 Competitive landscape: Market position analysis (based on products, regional presence and strategic initiatives)
Chapter 4 Immunohematology Market Product Estimates & Trend Analysis
                    4.1 Immunohematology Market: Product Movement Analysis
                    4.2 Immunohematology analyzer 
                         4.2.1 Immunohematology analyzer market estimates and forecasts, 2013 - 2024 (USD Million)
                    4.3 Immunohematology reagent
                         4.3.1 Immunohematology reagent market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 5 Immunohematology Market End-Use Estimates & Trend Analysis
                    5.1 Immunohematology Market: End-Use Movement Analysis
                    5.2 Hospitals
                         5.2.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.3 Blood banks
                         5.3.1 Blood banks market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.4 Diagnostic laboratories
                         5.4.1 Diagnostic laboratories market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6 Immunohematology Market: Regional Estimates & Trend Analysis
                    6.1 Regional Movement Analysis & Market Share, 2015 & 2024
                    6.2 North America
                         6.2.1 North America immunohematology market, by product, 2013 - 2024 (USD Million)
                         6.2.2 North America immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.2.3 U.S.
                              6.2.3.1 U.S. immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.2.3.2 U.S. immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.2.4 Canada
                              6.2.4.1 Canada immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.2.4.2 Canada immunohematology market, by end-use, 2013 - 2024 (USD Million)
                    6.3 Europe
                         6.3.1 Europe immunohematology market, by product, 2013 - 2024 (USD Million)
                         6.3.2 Europe immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.3.3 Germany
                              6.3.3.1 Germany immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.3.3.2 Germany immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.3.4 UK
                              6.3.4.1 UK immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.3.4.2 UK immunohematology market, by end-use, 2013 - 2024 (USD Million)
                    6.4 Asia Pacific
                         6.4.1 Asia Pacific immunohematology market, by product, 2013 - 2024 (USD Million)
                         6.4.2 Asia Pacific immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.4.3 Japan
                              6.4.3.1 Japan immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.4.3.2 Japan immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.4.4 China
                              6.4.4.1 China immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.4.4.2 China immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.4.5 India
                              6.4.5.1 India immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.4.5.2 India immunohematology market, by end-use, 2013 - 2024 (USD Million)
                    6.5 Latin America
                         6.5.1 Latin America immunohematology market, by product, 2013 - 2024 (USD Million)
                         6.5.2 Latin America immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.5.3 Brazil
                              6.5.3.1 Brazil immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.5.3.2 Brazil immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.5.4 Mexico
                              6.5.4.1 Mexico immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.5.4.2 Mexico immunohematology market, by end-use, 2013 - 2024 (USD Million)
                    6.6 MEA
                         6.6.1 MEA immunohematology market, by product, 2013 - 2024 (USD Million)
                         6.6.2 MEA immunohematology market, by end-use, 2013 - 2024 (USD Million)
                         6.6.3 South Africa
                              6.6.3.1 South Africa immunohematology market, by product, 2013 - 2024 (USD Million)
                              6.6.3.2 South Africa immunohematology market, by end-use, 2013 - 2024 (USD Million)
Chapter 7 Competitive Landscape
                    7.1 Strategy framework
                    7.2 Company Profiles
                    7.3 Bio-Rad Laboratories, Inc.
                         7.3.1 Company overview
                         7.3.2 Financial performance
                         7.3.3 Product benchmarking
                         7.3.4 Strategic initiatives
                    7.4 Immucor
                         7.4.1 Company overview
                         7.4.2 Financial performance
                         7.4.3 Product benchmarking
                         7.4.4 Strategic initiatives
                    7.5 Grifols
                         7.5.1 Company overview
                         7.5.2 Financial performance
                         7.5.3 Product benchmarking
                         7.5.4 Strategic initiatives
                    7.6 BD (Becton Dickinson)
                         7.6.1 Company overview
                         7.6.2 Financial performance
                         7.6.3 Product benchmarking
                         7.6.4 Strategic initiatives
                    7.7 Hologic, Inc.
                         7.7.1 Company overview
                         7.7.2 Financial performance
                         7.7.3 Product benchmarking
                         7.7.4 Strategic initiatives
                    7.8 Siemens Healthcare GmbH
                         7.8.1 Company overview
                         7.8.2 Financial performance
                         7.8.3 Product benchmarking
                         7.8.4 Strategic Initiatives
                    7.9 ThermoFisher
                         7.9.1 Company overview
                         7.9.2 Financial performance
                         7.9.3 Product benchmarking
                         7.9.4 Strategic initiatives
                    7.10 Abbott
                         7.10.1 Company overview
                         7.10.2 Financial performance
                         7.10.3 Product benchmarking
                         7.10.4 Strategic initiatives
                    7.11 Beckman Coulter, Inc.
                         7.11.1 Company overview
                         7.11.2 Financial performance
                         7.11.3 Product benchmarking
                         7.11.4 Strategic initiatives
                    7.12 Roche Diagnostics Corporation 
                         7.12.1 Company overview
                         7.12.2 Financial performance
                         7.12.3 Product benchmarking
                         7.12.4 Strategic initiatives

List of Tables


TABLE 1 Immunohematology ? global market current and forecast by regions (2015?2024) in (USD Million)
TABLE 2 North America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
TABLE 3 North America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 4 North America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 5 U.S. immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 6 U.S. immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 7 Canada immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 8 Canada immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 9 Europe immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
TABLE 10 Europe immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 11 Europe immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 12 UK immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 13 UK immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 14 Germany immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 15 Germany immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 16 Asia Pacific immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
TABLE 17 Asia Pacific immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 18 Asia Pacific immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 19 Japan immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 20 Japan immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 21 China immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 22 China immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 23 India immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 24 India immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 25 Latin America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
TABLE 26 Latin America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 27 Latin America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 28 Brazil immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 29 Brazil immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 30 Mexico immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 31 Mexico immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 32 MEA immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
TABLE 33 MEA immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 34 MEA immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
TABLE 35 South Africa immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
TABLE 36 South Africa immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)